Back to results
RecruitingPhase 2

Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)

NCT06512220

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Centre for Addiction and Mental Health

Toronto, Ontario, Canada

Contact

Muhammad Ishrat Husain, MBBS, MD

416-535-8501ishrat.husain@camh.ca
View on ClinicalTrials.gov
Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST) — TrialFind